Archemix's Series A Round

Archemix raised a round of funding on August 16, 2002.

Archemix discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases. The Company's aptamer product candidates include ARC1779 for throm…

Articles about Archemix's Series A Round: